ConductScience.org, home

Paper11368293

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Wallemacq PE and 1 other. Clin Pharmacokinet, 2001. Cited by 124 papers, by iCite.

Cite this record

ConductScience Library. Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Papers, record 11368293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11368293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2001
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
124
iCite
Relative citation ratio, by iCite
4.23
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wallemacq PEP E
2Verbeeck RKR K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
TacrolimusMajor topic
Adult
Chemical Phenomena
Chemistry, Physical
Child
Drug Interactions
Humans

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04645667Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)Background

Source ClinicalTrials.gov

Download CSV of trials

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12445721FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.J Antibiot (Tokyo)1987https://conductscience.org/library/papers/2445721PubMed
22445722FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.J Antibiot (Tokyo)1987https://conductscience.org/library/papers/2445722PubMed
31703356FK 506 inhibition of cyclosporine metabolism by human liver microsomes.Transplant Proc1991https://conductscience.org/library/papers/1703356PubMed
41377995Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood.Clin Chem1992https://conductscience.org/library/papers/1377995PubMed
59287412Comparison of old and new IMX assays for monitoring of tacrolimus levels.Transpl Int1997https://conductscience.org/library/papers/9287412PubMed
67693372FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.Clin Chem1993https://conductscience.org/library/papers/7693372PubMed
77680714Plasma protein binding of tacrolimus in humans.J Pharm Sci1993https://conductscience.org/library/papers/7680714PubMed
87537398Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients.Transplantation1995https://conductscience.org/library/papers/7537398PubMed
98585114Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay.Ther Drug Monit1995https://conductscience.org/library/papers/8585114PubMed
1010410178Diltiazem increases tacrolimus concentrations.Ann Pharmacother1999https://conductscience.org/library/papers/10410178PubMed
117533356Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations.Transplant Proc1995https://conductscience.org/library/papers/7533356PubMed
129664950Dosing of MMF in combination with tacrolimus for steroid-resistant vascular rejection in pediatric renal allografts.Transpl Int1998https://conductscience.org/library/papers/9664950PubMed
131721260Monitoring FK 506 concentrations in plasma and whole blood.Transplant Proc1991https://conductscience.org/library/papers/1721260PubMed
147544705HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients.Clin Chem1995https://conductscience.org/library/papers/7544705PubMed
1511294511Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.Ther Drug Monit2001https://conductscience.org/library/papers/11294511PubMed
167685933Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients.Transplantation1993https://conductscience.org/library/papers/7685933PubMed
179246018Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.Clin Pharmacol Ther1997https://conductscience.org/library/papers/9246018PubMed
182477714A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.Nature1989https://conductscience.org/library/papers/2477714PubMed
198721287Stability of FK506 in blood samples.Ther Drug Monit1996https://conductscience.org/library/papers/8721287PubMed
209269646Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9269646PubMed

See all 90 referencesDownload CSV of references

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.

PMIDTitleJournalYearIn PapersSource
42814375Structured Evaluation of Model-Informed Precision Dosing of Mycophenolic Acid and Tacrolimus in Pediatric Patients with Kidney Disease.Clin Pharmacokinet2026https://conductscience.org/library/papers/42814375PubMed
42758417Concentration-to-Dose Ratio Differences Between Once-Daily Tacrolimus Formulations: A Five-Year Real-World Pharmacokinetic Study in Kidney Transplantation.Eur J Drug Metab Pharmacokinet2026https://conductscience.org/library/papers/42758417PubMed
42338958Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects.Front Nephrol2026https://conductscience.org/library/papers/42338958PubMed
41531243Mechanism-informed machine learning for individualized tacrolimus dose adjustment in the early post-kidney transplant period.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41531243PubMed
41012521Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study.Pharmaceutics2025https://conductscience.org/library/papers/41012521PubMed
40908372Concentration-dependent blood binding: assessing implications through physiologically based Pharmacokinetic modeling of tacrolimus as a case example.J Pharmacokinet Pharmacodyn2025https://conductscience.org/library/papers/40908372PubMed
40528069Tacrolimus Trough Concentrations are Not Impacted by Epstein-Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients.Eur J Drug Metab Pharmacokinet2025https://conductscience.org/library/papers/40528069PubMed
39844338Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report.J Pharm Health Care Sci2025https://conductscience.org/library/papers/39844338PubMed
39836342Tacrolimus and diabetic rodent models.Pharmacol Rep2025https://conductscience.org/library/papers/39836342PubMed
39364052Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.Front Pharmacol2024https://conductscience.org/library/papers/39364052PubMed
38994750Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes.Br J Clin Pharmacol2024https://conductscience.org/library/papers/38994750PubMed
38993881Tacrolimus-why pharmacokinetics matter in the clinic.Front Transplant2023https://conductscience.org/library/papers/38993881PubMed
38947962Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation.World J Transplant2024https://conductscience.org/library/papers/38947962PubMed
38674430Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant.Genes (Basel)2024https://conductscience.org/library/papers/38674430PubMed
38286164Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38286164PubMed
37765200Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding.Pharmaceutics2023https://conductscience.org/library/papers/37765200PubMed
36119045The efficacy and safety of tacrolimus on top of glucocorticoids in the management of IIM-ILD: A retrospective and prospective study.Front Immunol2022https://conductscience.org/library/papers/36119045PubMed
35228813Prediction of Tacrolimus Dose/Weight-Adjusted Trough Concentration in Pediatric Refractory Nephrotic Syndrome: A Machine Learning Approach.Pharmgenomics Pers Med2022https://conductscience.org/library/papers/35228813PubMed
34817826Predictive Performance of Published Tacrolimus Population Pharmacokinetic Models in Thai Kidney Transplant Patients.Eur J Drug Metab Pharmacokinet2022https://conductscience.org/library/papers/34817826PubMed
34803692Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients.Front Pharmacol2021https://conductscience.org/library/papers/34803692PubMed

See all 61 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11368293

GET https://conductscience.org/api/papers/v1/11368293/references?page=2